Vagal Afferents and Visceral Pain

Author(s):  
Wilfrid Jänig
2008 ◽  
Vol 294 (6) ◽  
pp. G1441-G1449 ◽  
Author(s):  
S. L. Chen ◽  
X. Y. Wu ◽  
Z. J. Cao ◽  
J. Fan ◽  
M. Wang ◽  
...  

Activation of the vagal afferents by noxious gastrointestinal stimuli suggests that vagal afferents may play a complex role in visceral pain processes. The contribution of the vagus nerve to visceral pain remains unresolved. Previous studies reported that patients following chronic vagotomy have lower pain thresholds. The patient with irritable bowel syndrome has been shown alteration of vagal function. We hypothesize that vagal afferent nerves modulate visceral pain. Visceromotor responses (VMR) to graded colorectal distension (CRD) were recorded from the abdominal muscles in conscious rats. Chronic subdiaphragmatic vagus nerve sections induced 470, 106, 51, and 54% increases in VMR to CRD at 20, 40, 60 and 80 mmHg, respectively. Similarly, at light level of anesthesia, topical application of lidocaine to the subdiaphragmatic vagus nerve in rats increased VMR to CRD. Vagal afferent neuronal responses to low or high-intensity electrical vagal stimulation (EVS) of vagal afferent Aδ or C fibers were distinguished by calculating their conduction velocity. Low-intensity EVS of Aδ fibers (40 μA, 20 Hz, 0.5 ms for 30 s) reduced VMR to CRD at 40, 60, and 80 mmHg by 41, 52, and 58%, respectively. In contrast, high-intensity EVS of C fibers (400 μA, 1 Hz, 0.5 ms for 30 s) had no effect on VMR to CRD. In conclusion, we demonstrated that vagal afferent nerves modulate visceral pain. Low-intensity EVS that activates vagal afferent Aδ fibers reduced visceral pain. Thus EVS may potentially have a role in the treatment of chronic visceral pain.


2014 ◽  
Vol 15 (2) ◽  
pp. 204-217 ◽  
Author(s):  
Xiu-Juan Yan ◽  
Chen-Chen Feng ◽  
Qing Liu ◽  
Li-Yan Zhang ◽  
Xiao Dong ◽  
...  

2000 ◽  
Vol 279 (4) ◽  
pp. G781-G790 ◽  
Author(s):  
Anne-Marie Coelho ◽  
Jean Fioramonti ◽  
Lionel Buéno

Intraperitoneal lipopolysaccharide (LPS) produces somatic hyperalgesia, releases interleukin (IL)-1β and tumor necrosis factor-α (TNF-α), and activates vagal afferents. The aim of this study was to evaluate the effect of peripheral LPS on rectal sensitivity and to specify the mechanisms involved. Abdominal muscle contractions were recorded in conscious rats equipped with intramuscular electrodes. Rectal distension (RD) was performed at various times after LPS or experimental treatments. In controls, RD significantly increased the number of abdominal contractions from a threshold volume of distension of 0.8 ml. At the lowest volume (0.4 ml), this number was increased after administration of LPS (3, 9, and 12 h later), recombinant human IL-1β (from 3 to 9 h), recombinant bovine TNF-α (from 6 to 9 h), and BrX-537A (from 6 to 12 h), a mast cell degranulator. The effect of LPS was reduced by doxantrazole, Lys-d-Pro-Thr, and soluble recombinant TNF receptor. Vagotomy selectively amplified the response to LPS. We conclude that, in vivo, intraperitoneal LPS lowers visceral pain threshold (allodynia) through a mechanism involving mast cell degranulation and IL-1β and TNF-α release and that the vagus nerve may exert a tonic protective role against LPS-induced rectal allodynia.


2010 ◽  
Vol 34 (8) ◽  
pp. S22-S22
Author(s):  
Rong Wei ◽  
Ying Gao ◽  
Xiaoxue Ding ◽  
Ziqi Yue ◽  
Sha Wu ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A399-A399
Author(s):  
V LERAY ◽  
V SINNIGER ◽  
B ROCHE ◽  
M ODILECHRISTEN ◽  
S PHARMA ◽  
...  

2019 ◽  
Vol 3 (1) ◽  
Author(s):  
Eduardo E. Valdez-Morales ◽  
Tonatiuh Barrios-García ◽  
Alma Barajas-Espinosa ◽  
Raquel Guerrero Alba

Sign in / Sign up

Export Citation Format

Share Document